General Information of DME (ID: DEX2KIA)

DME Name Steroid 17-alpha-monooxygenase (CYP17A1) DME Info
Gene Name CYP17A1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Approved Drug(s)
Investigative Drug(s)
2 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aminophenazone DMY2AH1 N. A. N. A. Phase 4 [1]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [2]
------------------------------------------------------------------------------------
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexniguldipine DMLZIT2 Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 2 [3]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SODIUM PHOSPHATE, DIBASIC, ANHYDROUS DM1G4S9 Discovery agent N.A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Contribution of human hepatic cytochrome P450s and steroidogenic CYP17 to the N-demethylation of aminopyrine. Xenobiotica. 1999 Feb;29(2):187-93.
2 Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta. Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):2035-9.
3 In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17,20 LYASE) and molecular modelling studies. Biochem Pharmacol. 1997 Sep 1;54(5):605-11.
4 Transcriptional complexes at the CYP17 CRS. Endocr Res. 2002 Nov;28(4):551-8.